Treatment with thioredoxin, a cellular protein oxidoreductase synthesized by TXN gene expression, in the human cervical carcinoma cell line HeLa inhibited intracellular NF-κB pathway activation [105]. The gene discussed is NFKB1; the disease is cervical carcinoma.